Adjunct Instructor, Department of Medicine (Hematology/Oncology), UCSF
Yale University, CT, BS, 1998, Chemistry
Duke University, MD, 2002, Medicine
Residency, Internal Medicine, Brigham and Women's Hospital, Harvard Medical School
Clinical Instructor, Department of Medicine, University of California at San Francisco
Fellow, Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco
Adjunct Instructor, Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco
Honors & Awards
American Society of Hematology Research Training Award for Fellows, Finalist
American Medical Women's Association, Inc. Janet M. Glasgow Memorial Achievement Citation Awarded to graduating women medical students who graduate in the top 10% of their class.
E. E. Owen, M.D. Clinical Scholar Award Awarded to 2 graduating medical students for clinical excellence.
William G. Anylan Scholarship Awarded to 4th year medical students deserving recognition based on academics, service to the medical school and commitment to the profession.
Alpha Omega Alpha
Howard Hughes Medical Institute Research (HHMI) Medical Student Training Fellowship
Cum Laude, Yale University
Howard Douglass Moore Prize Awarded for excellence in the field of chemistry at Yale University.
Michael T. Manzella Award Presented to the senior who through the qualities of kindness, dedication and courage most inspired classmates in Timothy Dwight College at Yale.
National Institutes of Health (NIH) Summer Research Internship
Howard Hughes Medical Institute (HHMI) Summer Research Fellowship
Smith, C.C., Sempowski, GD, Rockey, DC. Increased Hepatic Fibrosis in Very Young Mice is Associated with Induction of Liver Natural Killer Cells [abstract]. Hepatology 2001; 34:394A.Carty, M., Smith, C.C., Schnipper, J., Intern Curriculum: The Impact of A Focused Training on the Process and Content of Signing Out Patients. Society of General Internal Medicine Annual Meeting, 2005. Poster presentation.Shah, NP; Wadleigh, M; Sokol, L; List, A; Cortes, J; Kantarjian, HM; Gilliland, DG; Olszynski, P; Smith, CC, Clary, DO; Bui, LA; and Verstovsek, S. A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis. ASH Annual Meeting Abstracts 2008 112: 98